Mannose Binding Lectin: A Potential Biomarker for Many Human Diseases

Author(s): Senjam Sunil Singh, Randy Chi Fai Cheung, Jack Ho Wong, Tzi Bun Ng

Journal Name: Current Medicinal Chemistry

Volume 23 , Issue 33 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Abstract:

The innate immune system plays a modulatory role in producing an inflammatory response during microbial infection and tissue regeneration. Mannose-binding lectin (MBL) is a predominant constituent of the innate immune system which initiates one of the complement activation, the lectin pathway. The activation of the complement system is also associated with many human diseases. We, therefore, try to summarize herewith the prognostic value of early detection of serum mannose-binding lectin (MBL) and measurement of its levels. The variant alleles and single nucleotide substitutions in MBL2 gene associated with MBL polymorphism are responsible for an increased risk of infection. Based on the currently available evidence, the role of MBL in humans is a double facet; sometimes its presence is associated with deterioration of the pathological condition while in other cases it is an important part of the body defense system. The importance of the determination of serum MBL as a diagnostic biomarker is duly addressed and then substitution of plasma-purified or recombinant MBL which can be a potential therapeutic for the treatment of human diseases is also highlighted. We have summarized in this article the pivotal roles of MBL in the early pathophysiology of various diseases and shown that MBL serves as a novel therapeutic target.

Keywords: Mannose binding lectins, innate immune system, polymorphism, complement activation, biomarker, therapeutic target.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 23
ISSUE: 33
Year: 2016
Page: [3847 - 3860]
Pages: 14
DOI: 10.2174/0929867323666160817162208
Price: $65

Article Metrics

PDF: 82
HTML: 11
EPUB: 1
PRC: 1